HilleVax (HLVX)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	105.40 mm	105.40 mm	105.40 mm	105.40 mm	105.40 mm	105.40 mm
Cash burn (monthly)	12.44 mm	4.55 mm	8.79 mm	12.53 mm	(no burn)	6.74 mm
Cash used (since last report)	34.81 mm	12.74 mm	24.61 mm	35.08 mm	n/a	18.87 mm
Cash remaining	70.58 mm	92.66 mm	80.78 mm	70.32 mm	n/a	86.52 mm
Runway (months of cash)	5.7	20.4	9.2	5.6	n/a	12.8

Beta Read what these cash burn values mean

Financial data from HilleVax earnings reports.

Institutional ownership, Q2 2024

HLVX institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	95	72	+31.9%
Opened positions	35	61	-42.6%
Closed positions	12	0	NEW
Increased positions	36	2	+1700.0%
Reduced positions	9	3	+200.0%

13F shares	Current	Prev Q	Change
Total value	509.26 bn	397.04 bn	+28.3%
Total shares	58.62 mm	46.91 mm	+25.0%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
Frazier Life Sciences Management	10.62 mm	$153.52 bn	+8.5%
Frazier Life Sciences Public Fund	8.54 mm	$107.89 mm	0.0%
TAK Takeda Pharmaceutical Company Limited	6.72 mm	$0.00	0.0%
Deerfield Management	4.00 mm	$57.90 bn	NEW
T. Rowe Price Investment Management	3.48 mm	$50.34 mm	+13.7%
Flynn James E	2.69 mm	$0.00	0.0%
BLK BlackRock	2.09 mm	$30.23 bn	+16.1%
BEN Franklin Resources	1.99 mm	$28.75 bn	+7.2%
Lightspeed Venture Partners Select IV	1.90 mm	$38.42 mm	0.0%
CG The Carlyle Group Inc.	1.84 mm	$26.44 bn	0.0%

Largest transactions	Shares	Bought/sold	Change
Deerfield Management	4.00 mm	+4.00 mm	NEW
Catalys Pacific	1.21 mm	+1.21 mm	NEW
JHG Janus Henderson	1.12 mm	+1.12 mm	NEW
Frazier Life Sciences Management	10.62 mm	+835.59 k	+8.5%
Samsara BioCapital	799.27 k	+799.27 k	NEW
Deep Track Capital	1.83 mm	-739.81 k	-28.8%
MPM Oncology Impact Management	645.09 k	+645.09 k	NEW
Citadel Advisors	531.82 k	+531.82 k	NEW
Millennium Management	489.98 k	+489.98 k	NEW
Point72 Asset Management	481.31 k	+481.31 k	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

HLVX insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
22 May 24	Aditya Kohli	Common Stock	Sell	Dispose S	No	Yes	14.7287	6,000	88.37 k	764,878
21 May 24	Aditya Kohli	Common Stock	Sell	Dispose S	No	Yes	14.205	6,000	85.23 k	770,878
20 May 24	Aditya Kohli	Common Stock	Sell	Dispose S	No	Yes	15.4482	6,000	92.69 k	776,878
3 May 24	Aditya Kohli	Common Stock	Sell	Dispose S	No	Yes	14.1542	723	10.23 k	782,878
2 May 24	Aditya Kohli	Common Stock	Sell	Dispose S	No	Yes	14.0135	6,000	84.08 k	783,601
1 May 24	Aditya Kohli	Common Stock	Sell	Dispose S	No	Yes	14.0343	175	2.46 k	789,601
5 Apr 24	Aditya Kohli	Common Stock	Sell	Dispose S	No	Yes	14.44	6,000	86.64 k	789,776
4 Apr 24	Frazier Life Sciences X	Common Stock	Buy	Acquire P	No	No	14.5	8,850	128.32 k	8,544,187
4 Apr 24	Aditya Kohli	Common Stock	Sell	Dispose S	No	Yes	14.7075	6,000	88.25 k	795,776
3 Apr 24	Aditya Kohli	Common Stock	Sell	Dispose S	No	Yes	14.9303	6,000	89.58 k	801,776

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

On December 4, 2024, Hillevax Commenced A Workforce Reduction Of 28 Employees, Constituting ~70% Of The Company's Workforce; Estimates That It Will Incur Charges Associated With The Workforce Reduction Of ~$6.1M

5 Dec 24

On December 4, 2024, HilleVax, Inc. (the "Company") commenced a workforce reduction of 28 employees, constituting approximately 70% of the Company's workforce, to reduce its operating expenses. The Company's remaining

HilleVax Q3 EPS $(0.52) Misses $(0.42) Estimate

7 Nov 24

HilleVax (NASDAQ:HLVX) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.42) by 23.81 percent. This is a 35.8 percent increase over losses of $(0.81) per share from the